📰 Immunisation Practices News
Page 4 - Immunisation Practices News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Immunisation Practices. Real-time updates on events, politics, business and more.
August 1, 2021
Can booster shots and mixing vaccines bolster our fight against Covid-19?
July 27, 2021
The World Health Organisation (WHO), yesterday, raised fresh safety concerns about Janssen and AstraZeneca vaccines. x A statement, by its Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on reports of Guillain-Barré Syndrome (GBS) following adenovirus vector COVID-19 vaccines, warned that vaccination with the Janssen and AstraZeneca jabs could cause rare immune system disorder that results in muscle weakness, pain, numbness and par...
July 11, 2021
Yasmeen Abutaleb, Tyler Pager, Laurie McGinley and Lena H. Sun11:52, Jul 11 2021 Pfizer is expected to brief top US government health officials in the coming days about the need for a coronavirus vaccine booster shot after an unusually public spat between the pharmaceutical giant and federal officials over whether a third shot will be necessary, according to the company and six people familiar with the plans. Pfizer and the German firm BioNTech announced last week that they planned to seek reg...
June 30, 2021
SINGAPORE - Singapore’s expert committee on Covid-19 vaccination and a senior infectious diseases specialist from the National Centre for Infectious Diseases (NCID) have come out to counter claims by a group of doctors behind an open letter arguing for a halt in the vaccination of young people here. In a revised statement issued on Monday (June 28), the Ministry of Health (MOH), which oversees the Expert Committee on Covid-19 Vaccination, said that news reports about a childs death in the U...
June 27, 2021
Health regulators in several countries have been investigating cases of myocarditis and pericarditis after a shot of Pfizer or Moderna. — Reuters/File WASHINGTON: The US drug regulator on Friday added a warning to the literature that accompanies Pfizer Inc /BioNTech and Moderna Covid vaccine shots to indicate the rare risk of heart inflammation after its use. For each vaccine, the fact sheets for healthcare providers have been revised to include a warning that reports of adverse events s...
June 26, 2021
WASHINGTON, June 26 ― The US drug regulator yesterday added a warning to the literature that accompanies Pfizer Inc /BioNTech and Moderna Covid vaccine shots to indicate the rare risk of heart inflammation after its use. For each vaccine, the fact sheets for healthcare providers have been revised...
June 26, 2021
WASHINGTON - The US drug regulator on Friday (June 25) added a warning to the literature that accompanies Pfizer Inc-BioNTech and Moderna Covid-19 vaccine shots to indicate the rare risk of heart inflammation after its use. For each vaccine, the fact sheets for healthcare providers have been revised to include a warning that reports of adverse events suggest increased risks...
June 12, 2021
The median age of patients who experienced the inflammation after a second vaccine dose was 24.. Read more at straitstimes.com.
June 1, 2021
Written by rjs, MarketWatch 666The news posted last week for the coronavirus 2019-nCoV (aka SARS-CoV-2), which produces COVID-19 disease, has been surveyed and some important articles are summarized here. The articles are more or less organized with general virus news and anecdotes first, then stories from around the US, followed by an increased number of items from other countries around the globe. Economic news related to COVID-19 is found here.
May 25, 2021
Moderna says its COVID-19 vaccine 100 per cent effective in 12-17 age group Representative Image WASHINGTON [US]: Moderna on Tuesday announced that various studies have shown its COVID-19 vaccine was 100 per cent effective at preventing infection in adolescents aged 12 to 17 and it planned on submitting the findings to global regulators in days. “We are encouraged that mRNA-1273 was highly effective at preventing COVID-19 in adolescents. It is particularly exciting to see that the Moderna COV...